Page last updated: 2024-08-21

3-hydroxyflavone and Kidney Diseases

3-hydroxyflavone has been researched along with Kidney Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Baltaci, AK; Ergene, N; Koc, A; Mogulkoc, R1
Chenxu, G; Jun, T; Linfeng, H; Mingxin, X; Minxuan, X; Qin, K; Xianling, D; Yan, S1
Fu, P; Guo, F; Ma, L; Ren, Q; Tao, S; Wang, B; Yang, L1
Bai, YF; Fan, XY; Lou, LJ; Wang, SW; Weng, YY; Xu, Y; Zhang, F; Zheng, XY1
Bi, X; Han, W; He, T; Jiang, W; Li, Y; Liu, C; Liu, Y; Xiao, T; Xiong, J; Xu, X; Yang, K; Yu, Y; Zhang, B; Zhang, J; Zhao, J1
Chen, L; Lan, Z; Li, F; Li, P; Yang, Z; Zhang, C; Zhang, X; Zhou, Y1

Other Studies

6 other study(ies) available for 3-hydroxyflavone and Kidney Diseases

ArticleYear
Effect of 3'-4'-dihydroxyflavonol on lipid per oxidation in experimental renal ischemia-reperfusion in rats.
    Pakistan journal of pharmaceutical sciences, 2019, Volume: 32, Issue:6

    Topics: Animals; Flavonols; Glutathione; Ischemia; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Malondialdehyde; Rats; Rats, Wistar; Reperfusion Injury

2019
Fisetin protects against high fat diet-induced nephropathy by inhibiting inflammation and oxidative stress via the blockage of iRhom2/NF-κB signaling.
    International immunopharmacology, 2021, Volume: 92

    Topics: Animals; Carrier Proteins; Cells, Cultured; Diet, High-Fat; Disease Models, Animal; Flavonoids; Flavonols; Gene Expression Regulation; Humans; Inflammation; Kidney Diseases; Macrophages; Male; Mice; NF-kappa B; Obesity; Oxidative Stress; Signal Transduction

2021
Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2021, Volume: 87

    Topics: Administration, Oral; Animals; Fibrosis; Flavonols; Gene Expression Regulation; Hyperuricemia; Interleukin-6; Janus Kinase 2; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Smad3 Protein; STAT3 Transcription Factor; Transforming Growth Factor beta; Uric Acid

2021
Astilbin ameliorates cisplatin-induced nephrotoxicity through reducing oxidative stress and inflammation.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2018, Volume: 114

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cisplatin; Flavonols; HEK293 Cells; Humans; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Oxidative Stress

2018
MicroRNA-34a Promotes Renal Fibrosis by Downregulation of Klotho in Tubular Epithelial Cells.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2019, 05-08, Volume: 27, Issue:5

    Topics: Animals; Cell Line; Disease Models, Animal; Doxorubicin; Epithelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Flavonols; Glucuronidase; Humans; Kidney; Kidney Diseases; Kidney Tubules; Klotho Proteins; Mice; MicroRNAs; Signal Transduction; Transforming Growth Factor beta1; Ureteral Obstruction

2019
Astilbin attenuates hyperuricemia and ameliorates nephropathy in fructose-induced hyperuricemic rats.
    Planta medica, 2011, Volume: 77, Issue:16

    Topics: Animals; Blood Urea Nitrogen; Connective Tissue Growth Factor; Creatinine; Dinoprostone; Disease Models, Animal; Drugs, Chinese Herbal; Flavonols; Fructose; Hyperuricemia; Interleukin-1; Kidney; Kidney Diseases; Male; Phytotherapy; Rats; Rats, Sprague-Dawley; Rhizome; Smilax; Transforming Growth Factor beta1; Uric Acid; Xanthine Oxidase

2011